Pharmacodynamic (PD) – Pharmacokinetic (PK) Study of Ficlatuzumab(F), A Monoclonal Antibody (MAB) Directed to the Hepatocyte Growth Factor (HGF), in Patients (PTS) with Advanced Solid Tumors who have Liver Metastases (METS) | Publicación